Itier Jean-Michel, Ibanez Pablo, Mena Maria Angeles, Abbas Nacer, Cohen-Salmon Charles, Bohme Georg Andrees, Laville Michel, Pratt Jeremy, Corti Olga, Pradier Laurent, Ret Gwenaelle, Joubert Chantal, Periquet Magali, Araujo Francisco, Negroni Julia, Casarejos Maria Jose, Canals Santiago, Solano Rosa, Serrano Alba, Gallego Eva, Sanchez Marina, Denefle Patrice, Benavides Jesus, Tremp Gunter, Rooney Thomas A, Brice Alexis, Garcia de Yebenes Justo
Functional Genomics Department, Aventis Pharma SA, Vitry-sur-Seine, France.
Hum Mol Genet. 2003 Sep 15;12(18):2277-91. doi: 10.1093/hmg/ddg239. Epub 2003 Jul 22.
Mutations of the parkin gene are the most frequent cause of early onset autosomal recessive parkinsonism (EO-AR). Here we show that inactivation of the parkin gene in mice results in motor and cognitive deficits, inhibition of amphetamine-induced dopamine release and inhibition of glutamate neurotransmission. The levels of dopamine are increased in the limbic brain areas of parkin mutant mice and there is a shift towards increased metabolism of dopamine by MAO. Although there was no evidence for a reduction of nigrostriatal dopamine neurons in the parkin mutant mice, the level of dopamine transporter protein was reduced in these animals, suggesting a decreased density of dopamine terminals, or adaptative changes in the nigrostriatal dopamine system. GSH levels were increased in the striatum and fetal mesencephalic neurons from parkin mutant mice, suggesting that a compensatory mechanism may protect dopamine neurons from neuronal death. These parkin mutant mice provide a valuable tool to better understand the preclinical deficits observed in patients with PD and to characterize the mechanisms leading to the degeneration of dopamine neurons that could provide new strategies for neuroprotection.
帕金基因的突变是早发性常染色体隐性帕金森病(EO-AR)最常见的病因。我们在此表明,小鼠中帕金基因的失活会导致运动和认知缺陷、抑制苯丙胺诱导的多巴胺释放以及抑制谷氨酸神经传递。帕金突变小鼠边缘脑区的多巴胺水平升高,并且存在多巴胺经单胺氧化酶代谢增加的趋势。虽然没有证据表明帕金突变小鼠中黑质纹状体多巴胺神经元减少,但这些动物中多巴胺转运蛋白水平降低,提示多巴胺终末密度降低,或黑质纹状体多巴胺系统发生适应性变化。帕金突变小鼠的纹状体和胎儿中脑神经元中的谷胱甘肽水平升高,提示一种代偿机制可能保护多巴胺神经元免于神经元死亡。这些帕金突变小鼠为更好地理解帕金森病患者中观察到的临床前缺陷以及确定导致多巴胺神经元变性的机制提供了有价值的工具,这可能为神经保护提供新策略。